302 related items for PubMed ID: 2172272
1. Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome.
Rabin DS, Schmidt PJ, Campbell G, Gold PW, Jensvold M, Rubinow DR, Chrousos GP.
J Clin Endocrinol Metab; 1990 Nov; 71(5):1158-62. PubMed ID: 2172272
[Abstract] [Full Text] [Related]
2. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ, Chrousos GP, Gold PW.
J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
[Abstract] [Full Text] [Related]
3. Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls.
Roca CA, Schmidt PJ, Altemus M, Deuster P, Danaceau MA, Putnam K, Rubinow DR.
J Clin Endocrinol Metab; 2003 Jul; 88(7):3057-63. PubMed ID: 12843143
[Abstract] [Full Text] [Related]
4. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
Inder WJ, Joyce PR, Ellis MJ, Evans MJ, Livesey JH, Donald RA.
Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
[Abstract] [Full Text] [Related]
5. Ovine corticotropin-releasing hormone stimulation test in patients with chronic renal failure: pharmacokinetic properties, and plasma adrenocorticotropic hormone and serum cortisol responses.
Siamopoulos KC, Eleftheriades EG, Pappas M, Sferopoulos G, Tsolas O.
Horm Res; 1988 Sep; 30(1):17-21. PubMed ID: 2851525
[Abstract] [Full Text] [Related]
6. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
Gold PW, Kling MA, Khan I, Calabrese JR, Kalogeras K, Post RM, Avgerinos PC, Loriaux DL, Chrousos GP.
Adv Biochem Psychopharmacol; 1987 Sep; 43():183-200. PubMed ID: 3035886
[Abstract] [Full Text] [Related]
7. ACTH and cortisol response to Dex/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement.
Lee EE, Nieman LK, Martinez PE, Harsh VL, Rubinow DR, Schmidt PJ.
J Clin Endocrinol Metab; 2012 Jun; 97(6):1887-96. PubMed ID: 22466349
[Abstract] [Full Text] [Related]
8. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V.
J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
[Abstract] [Full Text] [Related]
9. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB.
J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
[Abstract] [Full Text] [Related]
10. Premenstrual syndrome is associated with blunted cortisol reactivity to the TSST.
Huang Y, Zhou R, Wu M, Wang Q, Zhao Y.
Stress; 2015 May; 18(2):160-8. PubMed ID: 25518868
[Abstract] [Full Text] [Related]
11. Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome.
Facchinetti F, Fioroni L, Martignoni E, Sances G, Costa A, Genazzani AR.
Psychosom Med; 1994 May; 56(5):418-22. PubMed ID: 7809341
[Abstract] [Full Text] [Related]
12. Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration.
Vicennati V, Pasquali R.
J Clin Endocrinol Metab; 2000 Nov; 85(11):4093-8. PubMed ID: 11095438
[Abstract] [Full Text] [Related]
13. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
Feuillan P, Pang S, Schürmeyer T, Avgerinos PC, Chrousos GP.
J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
[Abstract] [Full Text] [Related]
14. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
Inder WJ, Prickett TC, Mulder RT.
Clin Endocrinol (Oxf); 2005 Mar; 62(3):343-8. PubMed ID: 15730417
[Abstract] [Full Text] [Related]
15. Allopregnanolone serum concentrations and diurnal cortisol secretion in women with premenstrual dysphoric disorder.
Segebladh B, Bannbers E, Moby L, Nyberg S, Bixo M, Bäckström T, Sundström Poromaa I.
Arch Womens Ment Health; 2013 Apr; 16(2):131-7. PubMed ID: 23329007
[Abstract] [Full Text] [Related]
16. Preliminary evidence for plasma adrenocorticotropin levels as biological correlates of premenstrual symptoms.
Redei E, Freeman EW.
Acta Endocrinol (Copenh); 1993 Jun; 128(6):536-42. PubMed ID: 8393259
[Abstract] [Full Text] [Related]
17. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis.
Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH.
Psychosom Med; 1999 Jun; 61(2):154-62. PubMed ID: 10204967
[Abstract] [Full Text] [Related]
18. Premenstrual syndrome is associated with altered cortisol awakening response.
Hou L, Huang Y, Zhou R.
Stress; 2019 Nov; 22(6):640-646. PubMed ID: 31057066
[Abstract] [Full Text] [Related]
19. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR.
Psychoneuroendocrinology; 2012 Aug; 37(8):1199-208. PubMed ID: 22277728
[Abstract] [Full Text] [Related]
20. Alterations in the hypothalamic-pituitary-ovarian and the hypothalamic-pituitary-adrenal axes in athletic women.
Loucks AB, Mortola JF, Girton L, Yen SS.
J Clin Endocrinol Metab; 1989 Feb; 68(2):402-11. PubMed ID: 2537332
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
